Compare Humana Inc (HUM) vs Global X Uranium ETF (URA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Global X Uranium ETF — how do they compare? Humana Inc trades at $449.75 (market cap $46.49B), while Global X Uranium ETF trades at $39.06 (market cap $5.48B). The key difference: Humana Inc is far larger — about 8.5× Global X Uranium ETF's market cap, and Humana Inc pays a 0.91% dividend while Global X Uranium ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Global X Uranium ETF for 62 Days on average.
| HUM | URA | |
|---|---|---|
Market Cap | $46.49B | $5.48B |
Volume | 2,567,704 | 5,287,170 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $409.85 | $61.81 |
52-Week Low | $163.67 | $37.52 |
Typical Hold Time | 53 Days | 62 Days |
Enterprise Value | $53.84B | — |
Dividend Yield | 0.91% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $441.74, up 11.41% over 24 hours, reflecting strong momentum. The stock shows bullish technical signals with support at $391 and resistance at $406. Fundamentally, revenue grew to $129.66B in 2025, though net income margin compressed to 0.88%. Recent news highlights a Barclays upgrade to a $515 price target and upcoming Q3 earnings on November 6, 2026.
The outlook is cautiously optimistic with a consensus price target of $457.05 implying modest upside. Risks include margin pressure from Medicare Advantage plan changes and potential regulatory scrutiny. Institutional activity is mixed, with Bank of America adding a position while some funds reduced stakes.
URA, the Global X Uranium ETF, trades at $39.93, down 4.47% today amid a bearish technical signal. The ETF is positioned in the nuclear energy sector, which is seeing increased attention due to AI-driven power demand and government support. Technical indicators show strong sell signals from moving averages, while oscillators are neutral. Recent news highlights a nuclear renaissance but also notes volatility in uranium equities.
The outlook for URA is mixed, with long-term growth potential from global nuclear expansion and AI energy needs, but near-term risks include commodity price sensitivity and sector volatility. Investors should weigh the ETF's concentrated exposure against broader nuclear infrastructure opportunities.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Global X Uranium ETF
URA provides broad exposure to the global uranium industry and nuclear energy sector. Unlike pure-play mining funds, it includes companies involved in nuclear component production and infrastructure, with top 2026 holdings such as Cameco, Oklo, and Uranium Energy Corp.
Read more on URA →
